# Tirzepatide Total-Cost Study: 3, 6 and 12 Months of Payments Publisher: Tirzepatide Report Author: Alan Pierce, Clinical Pharmacology Writer Canonical: https://tirzepatidereport.com/tirzepatide-total-cost-study Published: 2026-10-06 Updated: 2026-10-18 Coverage: full article text A dated four-provider cost study separating 28-day refills, monthly memberships, introductory prices and prepaid plans, with reproducible calculations. **A tirzepatide price advertised “per month” is not enough to calculate your yearly budget.** Some plans renew every 28 days, some charge a separate membership, and an annual-plan headline may require paying the full commitment upfront. Our October 2026 review of four published offers shows how those differences change 3-, 6- and 12-month cash outlays. This is a limited, reproducible pricing study, not a survey of every provider or a clinical ranking. We checked Eden, Pallas Health, Willow and Ro because their public pages illustrate different billing structures. We did not enroll, buy medication or observe patient spending. Prices and terms were checked October 6, 2026; future totals are scenarios holding those inputs constant, not quotes or guarantees.[1][2][3][4] Compounded drugs are not FDA-approved. FDA does not review their safety, effectiveness or quality before marketing, and a published offer does not establish that compounded treatment is appropriate or legally available for a particular person. This study compares payment structures, not equivalence to approved Zepbound.[5] ## The four inputs we actually verified **Eden:** its weight-loss page displays compounded tirzepatide at $129 per month, at every dose, with no separate membership. We model that published monthly price without an introductory discount. Exact shipment timing and the final prescribed product still need confirmation.[1] **Pallas Health:** the public compounded-tirzepatide offer is $179 for the first period and $299 every four weeks afterward. Provider care and shipping are included without a separate membership. The page advertises the same compounded-plan price across doses. We exclude its annual-plan alternative from the main calculation.[2] **Willow:** its compounded-tirzepatide page displays $399 per month. We model a stable $399 monthly quote as a conditional scenario, not a guarantee across future prescriptions or dose changes. Confirm the final recurring amount and any additional charges before paying.[3] **Ro:** its monthly membership is $39 for the first month and $149 thereafter. Medication is a separate charge. We show membership alone, rather than make up a total prescription price or assume everyone qualifies for the same manufacturer program.[4] All four are cash-payment scenarios. Insurance reimbursement, tax treatment, financing interest, optional services and any unlisted charges are excluded. A provider's “included” claim comes from its public page; it is not a finding from our own purchase or inspection of a patient invoice. ## What the 3-, 6- and 12-month table means We model starting on **October 6, 2026**, with payment at the start of each billing period. The horizons end on January 6, April 6 and October 6, 2027: 92, 182 and 365 days after the start. Payments due on the ending anniversary are excluded; a payment due before it is included. For the advertised monthly offers, we assume calendar-month billing, producing 3, 6 and 12 payments. This assumption must be checked at checkout: if “monthly” actually means every 28 days, those totals change. Pallas explicitly specifies four-week renewal, so its corresponding payment counts are 4, 7 and 14. A shorter billing interval needs its own model. The [WellMedr review](/wellmedr-tirzepatide-review) examines a policy with a 21-day recurring plan, which can produce up to 18 charges in the first 365 days including checkout. That rule applies to the selected 21-day plan, not automatically to every advertised offer. WellMedr is outside this study’s four-provider calculation; obtain the accepted charge schedule before projecting a year.[14] Modeled cash payments before three, six and twelve calendar-month anniversaries | Payment scenario | 3 months | 6 months | 12 months | | --- | --- | --- | --- | | Eden: $129/month assumption | $387 | $774 | $1,548 | | Pallas: $179 then $299/28 days | $1,076 | $1,973 | $4,066 | | Willow: stable $399/month assumption | $1,197 | $2,394 | $4,788 | | Ro membership ONLY: $39 then $149/month | $337 + medication | $784 + medication | $1,678 + medication | Start October 6, 2026. Pallas has 4/7/14 charges; other rows assume 3/6/12 calendar-month charges. No prepayment, taxes, optional extras or price changes. Different products and services; not a clinical ranking. These are **cash paid by the horizon**, not the value of medicine consumed by that date. The fourteenth Pallas payment falls on day 364 and purchases a period extending beyond the one-year horizon. We include it because the question is how much cash leaves the account before the anniversary. We do not pretend that fourteen four-week periods equal one year. Outside this study’s four-provider calculation, the [TrueMe review](/trueme-tirzepatide-review) examines a public three-month $99 monthly equivalent with $297 due today, alongside different amounts on its separate weight-loss page. Confirm the selected plan and full charge before entering a monthly equivalent into a cash-flow budget.[16][17] Ro's membership row cannot be compared as a complete treatment price against rows that include the advertised medication. Add the actual medication quote and its own refill schedule. For example, a $149 membership and a $399 drug charge are two charges; the membership headline is not the treatment total. ## Reproduce every number For Eden's monthly scenario, multiply **$129 × number of monthly payments**. For Willow's conditional monthly scenario, use **$399 × number of monthly payments**. For Pallas, use **$179 + $299 × (number of four-week payments − 1)**. With a charge on day zero, the number of payments before an endpoint is the endpoint's day count divided by 28, rounded upward. At 92 days that is four charges: $179 + 3 × $299 = $1,076. At 182 days it is seven charges, or $1,973. At 365 days it is fourteen charges, or $4,066. For Ro membership, use **$39 + $149 × (number of monthly payments − 1)**. The resulting $337, $784 and $1,678 still exclude medication. Do not add a manufacturer discount twice or assume a membership includes the pharmacy bill. For readers who prefer refill-cycle comparisons, Pallas costs **$777 for three four-week periods, $1,674 for six, and $3,468 for twelve**. Those cover 84, 168 and 336 days, respectively. Thirteen periods cost $3,767 and cover 364 days. These are different questions from the cash-paid-by-calendar-anniversary table above. ## Why an introductory price has a smaller annual effect The Pallas introductory period is $120 below its recurring four-week charge. In the modeled fourteen-payment year, that saves $120 against fourteen recurring-price payments, not $120 every month. Ro's first membership charge is $110 below the recurring monthly charge, so its introductory benefit is likewise a single $110 reduction. This simple arithmetic is often more informative than multiplying the first advertised price by twelve. An introductory offer can make starting less expensive while leaving the long-term budget largely determined by the recurring price and billing frequency. There is also a timing tradeoff. Paying on a four-week schedule brings the next renewal earlier in the calendar each cycle. Two offers with the same numerical “monthly” price may therefore have different anniversary cash outlays. Ask for the actual renewal interval in days or calendar months. ## Prepayment changes the cash commitment Ro advertises lower membership averages for prepaid terms: $99 per month for three months, $89 for six and $74 for twelve. Those correspond to nominal term charges of $297, $534 and $888 before considering how an introductory month interacts with the selected plan. They are not promises of paying only $74 each month on the annual option.[4] We exclude prepaid variants from the main table because they create a different question: how much money is committed before knowing whether the full term will be used? Ask when the prepaid term begins, what happens if treatment is not prescribed, and which portions are refundable after prescribing or dispensing. The [SnagRx review](/snagrx-tirzepatide-review) gives a separate example in which the lowest monthly equivalent requires the full annual payment upfront. Outside this study’s calculations, the [Yes Clinic review](/yes-clinic-tirzepatide-review) describes $894 upfront for six months, with a clinical check-in before the second shipment. The product promises a $447 refund if that part is declined or the check-in deadline is missed. Dispensed medication generally remains nonrefundable. Compare that specific protection with the total prepayment.[20][21] A generic hypothetical illustrates the distinction. An annual service costing $900 upfront averages $75 per month if used for twelve months. If you stop after three months and no refund applies, your cash outlay remains $900, not $225. That example is arithmetic, not a claim about any provider's refund policy. For additional examples outside this four-provider calculation, the [Eloria review](/eloria-tirzepatide-review) examines introductory and prepaid-plan terms, while the [Näky Health review](/naky-tirzepatide-review) distinguishes a one-month purchase from longer-plan equivalents. Compare the selected commitment and refund rules before carrying a headline into a yearly budget. ## A sensitivity check is better than false precision For a monthly-billed plan, an additional mandatory $50 fee each month adds $150, $300 and $600 across the three horizons. If a recurring price rises by $100 after the first three payments, it adds $300 over six monthly payments and $900 over twelve. Neither scenario predicts a provider's price change; it shows why missing recurring charges matter more as treatment continues. A quote should also state whether the amount changes with prescribed dose, whether shipping or supplies are separate, and whether the plan includes clinician follow-up. Do not choose or alter a dose to make a spreadsheet work. Medical decisions determine the prescription; the budget should reflect it. The [KERNX Health review](/kernx-health-tirzepatide-review) provides a supply-period example outside this model: its prepaid twelve-month term covers thirteen four-week supplies. Confirm the supply duration and payment dates separately before calculating an annual budget. The [Potere Health MD review](/potere-health-md-tirzepatide-review) illustrates a quantity-based budget outside this study’s calculations: its starting offer is $350 upfront for 60 mg, advertised as up to twelve weeks during starting titration. That is not a fixed monthly refill or a $117 installment. Confirm the prescribed regimen, usable period and refill timing before projecting the vial price across a year.[15] The [BioGlow Health review](/bioglow-health-tirzepatide-review) illustrates another quantity distinction outside this study’s calculations: its shop labels tirzepatide options as 10–60 mg per month, not weekly doses. A separate $399 three-month bundle does not establish its contents or renewal schedule. Confirm those details before projecting a monthly or yearly budget.[19] Willow's row is especially sensitive to the assumption that the eventual quoted price stays at $399. Eden's calendar-month timing is an explicit modeling assumption. We keep those limitations visible instead of turning a public headline into a guaranteed twelve-month contract. ## Why approved-brand costs need their own calculation Lilly's current Zepbound offers distinguish product formats, insurance status and eligibility. Some offers have refill conditions, annual limits and an end date of December 31, 2026. A twelve-month projection beginning in October 2026 crosses that end date, so we do not assume the same savings continue into 2027.[6] Use the [Zepbound cost and savings guide](/zepbound-cost-and-savings) to identify the applicable route and request a quote. Then add any prescribing-service membership. A manufacturer medication price and a telehealth program price answer different parts of the budget. Employer benefits need another calculation. The [Virta Health review](/virta-health-tirzepatide-review) examines 2026 AlaskaCare and IAM Medical Plan D documents naming Zepbound and Virta prescribing requirements. These defined benefits do not supply a universal cash price; use your own sponsor’s eligibility, pharmacy rules and patient share rather than entering another plan’s terms into this self-pay comparison.[7][8] A partial subsidy requires the remaining balance to be calculated separately. The [Vida Health review](/vida-health-tirzepatide-review) describes Currituck County’s RxSaveCard funding and GiftHealth checkout for Zepbound in its 2026–2027 benefit. Confirm the card balance, medication charge and any personal shortfall before comparing that route with a cash-pay plan. The sponsor document supplies no universal member total, and this benefit is outside the study’s four-provider calculations.[11] ## What this sample leaves out We did not include every provider in the [price index](/data/tirzepatide-price-index), apply insurance deductibles, model dose selection or assume unused medication can be returned. We also exclude annual Pallas pricing, Ro prepaid memberships and individualized offers whose timing or total commitment differs from the main scenarios. Excluding a provider or plan is not a judgment of its clinical quality. The sample is selected for clear examples of billing differences, not random market representation. It cannot establish the national average cost, the cheapest legitimate provider or which service offers better outcomes. Affiliate relationships do not enter these equations. The provider reviews give the broader context: [Eden](/eden-tirzepatide-review), [Pallas](/pallas-health-tirzepatide-review), [Willow](/willow-tirzepatide-review) and [Ro](/ro-tirzepatide-review). ## Before you pay, ask for these five answers 1. What is the first charge, and what is each recurring charge? 2. Does renewal occur every 28 days or on a calendar-month schedule? 3. Is medication included, and can the price change with the prescription? 4. What must be prepaid, and what refund rules apply after prescribing or dispensing? 5. What happens to charges and care if treatment stops or eligibility changes? Save the written quote and terms. That is the bridge between a useful published comparison and your actual financial commitment. Recheck this study's dated inputs against the provider before enrolling, especially when budgeting beyond an offer's stated term. Our [Aesthetic Concierge review](/the-aesthetic-concierge-tirzepatide-review) examines a five-week payment unit, another interval to resolve before making an annual budget. That program is outside this study’s calculation. A selected quote also matters when public product pages differ. The [Nuform Health review](/nuform-health-tirzepatide-review) distinguishes named tirzepatide batch amounts loaded by its public intake from a different starter-kit headline on its marketing page. Unselected catalog values and divided monthly equivalents do not confirm your selected total. Request the batch charge, separate care fee, supply and renewal schedule together before entering the purchase into an annual budget.[12][13] Compare additional subscription, prescribing and pharmacy arrangements in our [tirzepatide care options guide](/tirzepatide-care-options). Each program review explains its own payment unit and any published commitment. ## Comparing a flexible visit with a treatment commitment A “no subscription” service can still leave you paying separately for medication, repeat visits, labs or refill evaluation. A subscription can include some of those services while committing you to payments you cannot cancel after fulfillment. Compare the same treatment period and list what each payment actually buys. The [Bodyshop Wellness review](/bodyshop-wellness-tirzepatide-review) provides a care-timing example outside this study’s calculations. Its site says to repeat enrollment, lab review and medication steps every 90 days. That does not establish a 90-day supply or three-month payment commitment. Obtain the actual supplied period and charge schedule before projecting an annual budget.[18] Before paying, ask when a medication order becomes nonrefundable, whether cancellation stops care as well as billing, and how future prescriptions are handled. Do not treat an advertised monthly equivalent for a prepaid term as a month-to-month contract. If you now have a possible insurance route, compare its verified quote; the [Caremark coverage update](/cvs-caremark-zepbound-coverage) explains one important recent formulary change. The [Zeuss review](/zeuss-tirzepatide-review) separates a one-time purchase from subscription renewals and explains how a completed consultation or pharmacy processing can limit a refund. The [EllieMD review](/elliemd-tirzepatide-review) provides a concrete commitment example outside this study’s calculations: its weight-management terms require at least three months, and cancellation during the active term does not remove remaining installments. An installment schedule spreads payments; it does not establish that the purchase can be ended after a single payment.[9][10] Frequently asked questions: Q: How much does tirzepatide cost over 3, 6 or 12 months in this study? A: In the three medication-inclusive public-price scenarios, modeled cash outlays range from $387–$1,197 over three calendar months, $774–$2,394 over six, and $1,548–$4,788 over twelve. These are a limited compounded-provider sample with explicit timing and unchanged-price assumptions, not market averages or clinical equivalents to Zepbound. Ro is shown separately as membership only, with medication additional. Q: Why can a four-week plan have fourteen charges before a one-year anniversary? A: With a payment on day zero and every 28 days thereafter, another charge falls on day 364. That charge occurs before a 365-day anniversary and buys a period extending beyond it. Thirteen four-week supplies cover 364 days. Q: Is the Ro total a medication-inclusive price? A: No. The modeled totals are membership alone: $39 initially and $149 monthly thereafter. Medication is a separate charge and must be added using its actual quote and refill schedule. Q: Are these guaranteed future prices? A: No. These are calculations holding October 6, 2026 public prices constant. Billing timing, prescription changes, eligibility and future terms can change the amount paid. Q: Does a lower compounded price mean it is equivalent to Zepbound? A: No. Compounded drugs are not FDA-approved. A price comparison does not establish equivalent safety, effectiveness, quality or suitability. References: [1] Eden. GLP-1 weight-loss pricing: public tirzepatide offer, checked October 6, 2026 Provider pricing page (2026). [2] Pallas Health. Public pricing and renewal terms, checked October 6, 2026 Provider homepage (2026). [3] Willow. Compounded tirzepatide public price, checked October 6, 2026 Provider product page (2026). [4] Ro. Weight Loss Program Pricing, checked October 6, 2026 Provider pricing page (2026). [5] U.S. Food and Drug Administration. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss FDA (2026). https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss [6] Eli Lilly and Company. Zepbound savings offers and terms, checked October 6, 2026 Manufacturer program terms (2026). https://zepbound.lilly.com/savings [7] Alaska Division of Retirement and Benefits. 2026 Open Enrollment Guide, page 4 Alaska Division of Retirement and Benefits (2026). https://drb.alaska.gov/docs/materials/EmployeeOEGuide_WEB.pdf [8] National IAM Benefit Trust Fund. Medical Plan D Summary of Material Modifications, effective January 1, 2026 National IAM Benefit Trust Fund (2026). https://www.iambtf.org/sites/iambtf.org/files/1923%20-%20NATIONAL%20IAM%20BENEFIT%20TRUST%20FUND%20-%20SMM%201.1.26%20-%20Plan%20D%20draft%2010.2.25%20-%20Branded.pdf [9] EllieMD. Terms and Conditions EllieMD (2026). [10] EllieMD. Refund and Return Policy EllieMD (2026). [11] Currituck County. 2026–2027 Benefits Enrollment Guide, pages 11 and 14 Currituck County (2026). https://currituckcountync.gov/wp-content/uploads/26-27-benefits-guide.pdf [12] Nuform Health. Public intake and linked named-product catalog Nuform Health (2026). [13] Nuform Health. GLP-1/GIP program: care, batch prices and pharmacy description Nuform Health (2026). [14] WellMedr. Refund, Cancellation & Subscription Policy: billing and documented fulfillment WellMedr (2026). [15] Potere Health MD. Detailed compounded GLP-1 pricing Potere Health MD (2026). [16] TrueMe. GLP-1/GIP tirzepatide product and states TrueMe (2026). [17] TrueMe. Weight-loss program page TrueMe (2026). [18] Bodyshop Wellness. Medically Assisted Weight Management: named tirzepatide and care sequence (accessed October 24, 2026; publication date not displayed) Bodyshop Wellness official public website (2026). [19] BioGlow Health. Shop: injectable tirzepatide monthly quantities and three-month bundle (accessed October 24, 2026; publication date not displayed) BioGlow Health official public website (2026). [20] Yes Clinic. Program and prescription information Yes Clinic (2026). [21] Yes Clinic. Terms, policy or service details Yes Clinic (2026).